It has been shown that IFN-γ pathway-associated gene deletions can impair antigen presentation in melanomas of the head and neck region, ultimately leading to immune escape and radiotherapy resistance in HNSCC.180. Here, IFNG is linked to head and neck squamous cell carcinoma.